Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiodarone-induced thyrotoxicosis: not a benign condition.

P M Leung1, N D Quinn, P E Belchetz

  • 1Department of Endocrinology, The General Infirmary, Leeds, UK.

International Journal of Clinical Practice
|February 8, 2002
PubMed
Summary

Amiodarone, an antiarrhythmic drug, can cause thyrotoxicosis, a serious thyroid condition. This condition is often underestimated and challenging to treat, requiring careful management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene.

Diabetologia·2004
Same author

Emergency management of diabetic ketoacidosis in adults.

Emergency medicine journal : EMJ·2003
Same author

Lesson of the week: unsuspected central hypothyroidism.

BMJ (Clinical research ed.)·2000
Same author

Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial--an early report.

British journal of neurosurgery·2000
Same author

Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication.

Clinical endocrinology·1998
Same author

Re-irradiation for locally recurrent nasopharyngeal carcinoma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·1998

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Amiodarone is a widely used antiarrhythmic medication for tachyarrhythmias.
  • Its efficacy is balanced by potential severe side effects.
  • Thyroid dysfunction, specifically thyrotoxicosis, is a recognized complication.

Observation:

  • This report details several cases of amiodarone-induced thyrotoxicosis.
  • These cases illustrate the significant clinical challenges associated with this condition.
  • The severity and management difficulties are highlighted.

Findings:

  • Amiodarone-induced thyrotoxicosis presents significant treatment challenges.
  • The potential consequences of this side effect are often underestimated.
  • Effective management requires specialized medical expertise.

Related Experiment Videos

Implications:

  • Clinicians should be vigilant for amiodarone-induced thyrotoxicosis in patients on this medication.
  • Further research into optimizing treatment strategies for amiodarone-induced thyrotoxicosis is warranted.
  • Raising awareness of this complication can improve patient outcomes.